The protective effects of IL-33 and IL-25 for intestinal parasitic infections are largely dependent on the activation of ILC2 which express IL-33 receptor ST2 and IL-25 receptor IL17RB (Mathä et al., 2022). The gene discussed is IL25; the disease is parasitic intestinal disorder.